NRX Pharmaceuticals Analyst Ratings
NRX Pharmaceuticals Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2022 | 367.89% | Ascendiant Capital | → $4 | Initiates Coverage On | → Buy |
| 06/30/2022 | 133.95% | HC Wainwright & Co. | → $2 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析師事務所 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/09/2022 | 367.89% | 上升資本 | → 4 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 06/30/2022 | 133.95% | HC Wainwright & Co. | → 2 美元 | 啓動覆蓋範圍開啓 | → 購買 |
NRX Pharmaceuticals Questions & Answers
NRX 製藥問題與解答
The latest price target for NRX Pharmaceuticals (NASDAQ: NRXP) was reported by Ascendiant Capital on November 9, 2022. The analyst firm set a price target for $4.00 expecting NRXP to rise to within 12 months (a possible 367.89% upside). 2 analyst firms have reported ratings in the last year.
Ascendiant Capital於2022年11月9日公佈了NRX製藥公司（納斯達克股票代碼：NRXP）的最新目標股價。該分析公司將目標股價定爲4.00美元，預計NRXP將在12個月內上漲至4.00美元（可能上漲367.89％）。去年有兩家分析公司公佈了評級。
The latest analyst rating for NRX Pharmaceuticals (NASDAQ: NRXP) was provided by Ascendiant Capital, and NRX Pharmaceuticals initiated their buy rating.
NRX Pharmicals（納斯達克股票代碼：NRXP）的最新分析師評級由Ascendiant Capital提供，NRX Pharmicals啓動了買入評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NRX Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NRX Pharmaceuticals was filed on November 9, 2022 so you should expect the next rating to be made available sometime around November 9, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與NRX Pharmicals的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。NRX Pharmicals的最新評級是在2022年11月9日提交的，因此您應該預計下一個評級將在2023年11月9日左右公佈。
While ratings are subjective and will change, the latest NRX Pharmaceuticals (NRXP) rating was a initiated with a price target of $0.00 to $4.00. The current price NRX Pharmaceuticals (NRXP) is trading at is $0.85, which is within the analyst's predicted range.
儘管評級是主觀的，並將發生變化，但最新的NRX製藥公司（NRXP）評級是啓動的，目標股價爲0.00美元至4.00美元。NRX Pharmicals（NRXP）目前的交易價格爲0.85美元，在分析師的預測區間內。